- ASSISTANT PROFESSOR Rehabilitation Medicine
Ph.D., City University of New York
North Shore University Hospital
Mount Sinai Hospital
Dr. Krellman is a clinical neuropsychologist and brain injury rehabilitation researcher who holds the rank of Assistant Professor in the Department of Rehabilitation Medicine. He comes to Mount Sinai from the Rusk Institute of Rehabilitation Medicine at NYU-Langone Medical Center, where he served as a staff neuropsychologist and Clinical Instructor of Rehabilitation Medicine.
Dr. Krellman has extensive training and experience in neuropsychological evaluation, cognitive remediation, and psychotherapy with patients experiencing a variety of neurological and psychiatric disorders, including dementia, movement disorders, acquired brain injuries, depression, and anxiety. He uses his background in neuroscience and medical neuropsychology to inform his cognitive evaluations, which are aimed at identifying targets and methods for effective treatment and addressing practical issues relevant to patients' everyday lives, such as return-to-work decisions. His approach to cognitive remediation and psychotherapy is individualized based on patients' specific symptoms, life roles, ethnic and cultural background, and personal values.
Dr. Krellman's primary research interests include attrition in longitudinal studies of persons with traumatic brain injury (TBI), culturally-sensitive educational interventions for persons with TBI, and both biological and psychological factors associated with persistent functional deficits following mild TBI. Within the Brain Injury Research Center (BIRC) at Mount Sinai, Dr. Krellman is actively involved in a number of research projects funded by the National Institute on Disability and Rehabilitation Research (NIDRR) and the Centers for Disease Control (CDC). He also serves as Director of Clinical Training for the BIRC's NIDRR-funded post-doctoral fellowship in clinical neuropsychology and rehabilitation research, of which he is a graduate.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Krellman did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Faculty Practice Associates Floor B Room FB-07
5 East 98th Street
New York, NY 10029
5 East 98th St.
New York, NY 10029